InsiderTrades

Form 4 for ATEC Alphatec Holdings, Inc.

Accepted 2023-01-26 00:00:00 ET · period of report 2023-01-25 · accession 0001567619-23-001321 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-01-26 2023-01-25 ATEC L-5 Healthcare Partners, LLC 10%, Dir by deputization F - Tax $13.14 -532.5K 11.00M -5% -$7.00M
D 2023-01-26 2023-01-25 ATEC L-5 Healthcare Partners, LLC 10%, Dir by deputization M - OptEx $3.50 +2.00M 11.53M +21% +$7.00M
D 2023-01-26 2023-01-25 ATEC L-5 Healthcare Partners, LLC 10%, Dir by deputization X - OptEx $0.00 -2.00M 2.35M -46% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-01-25 F D 532,513 $13.14 10,997,833 D — — (F3) Represents a "cashless exercise" of outstanding warrants. The reporting person received 1,467,487 shares of Common Stock on cashless exercise of warrants to purchase 2,000,000 shares of Common Stock. The Company withheld 532,513 shares of Common Stock underlying the warrants for payment of the exercise price, using the VWAP on January 24, 2023 of approximately $13.14, pursuant to the terms of the warrant. (F4) Paul Segal separately is the direct beneficial owner of 338,825 shares of Common Stock of the Issuer. (F2) Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein. (F1) Each of Andy Barnett and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act.
2 Common Common Stock 2023-01-25 M A 2,000,000 $3.50 11,530,346 D — — (F4) Paul Segal separately is the direct beneficial owner of 338,825 shares of Common Stock of the Issuer. (F2) Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein. (F1) Each of Andy Barnett and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act.
3 Derivative Warrants to Purchase Common Stock 2023-01-25 X D 2,000,000 $0.00 2,346,032 D $3.50 · 2018-05-17 to 2023-05-17 2,000,000 Common Stock (F2) Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein. (F1) Each of Andy Barnett and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act.